KYTX
Kyverna Therapeutics, Inc.
7.10$
-0.1%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
Kyverna Therapeutics, Inc. (KYTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -154 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| -22 | -36 | -52 | -114 | -154 | |
| 0.6 | 1.1 | 1.7 | 2.1 | 1.8 | |
| 7.3 | 0.9 | 2.2 | 8.4 | 10 | |
| -4.5 | -10 | 3.4 | 7.9 | -1.1 | |
| 1.3 | 0.8 | 0.6 | 2.2 | 0.0 | |
| -1.3 | -14 | -8.8 | -161 | 40 | |
| 0.0 | -0.2 | -0.8 | -1.0 | -0.8 | |
| 73 | 12 | 58 | 337 | 141 | |
| 49 | -38 | -3.1 | 62 | 27 | |
| -23 | -37 | -53 | -116 | -154 |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.